SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-068984
Filing Date
2024-08-14
Accepted
2024-08-14 16:05:24
Documents
69
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0210807-10q_chinaphar.htm   iXBRL 10-Q 605869
2 CERTIFICATION ea021080701ex31-1_china.htm EX-31.1 10029
3 CERTIFICATION ea021080701ex31-2_china.htm EX-31.2 9938
4 CERTIFICATION ea021080701ex32-1_china.htm EX-32.1 5484
  Complete submission text file 0001213900-24-068984.txt   4369170

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cphi-20240630.xsd EX-101.SCH 44792
6 XBRL CALCULATION FILE cphi-20240630_cal.xml EX-101.CAL 41945
7 XBRL DEFINITION FILE cphi-20240630_def.xml EX-101.DEF 232027
8 XBRL LABEL FILE cphi-20240630_lab.xml EX-101.LAB 415724
9 XBRL PRESENTATION FILE cphi-20240630_pre.xml EX-101.PRE 238936
72 EXTRACTED XBRL INSTANCE DOCUMENT ea0210807-10q_chinaphar_htm.xml XML 391892
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

IRS No.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34471 | Film No.: 241207478
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)